No abstract

In the early part of the 20th century, veterinarians began to perform Caesarean section (CS) in cows. At first, it was a final remedy to save the calf and/or the cow in more complicated obstetrical cases. As in Belgium, the Belgian Blue (BB) breed has become the predominant beef breed, CS are currently performed on a routine basis in daily practice. The overwhelming success of the breed is based on its hypermuscularity and exceptional carcass characteristics with high killing out (>70%). These and other characteristics made the breed popular and newborn animals valuable. Consequently, farmers do not want to take any risk of losing the calf during birth. This, together with the fact that bovine practitioners perform CS successfully on a routine basis, has made CS an elective operation. It is, however, important to remember that CS is still a major abdominal operation and that complications are not uncommon both during and after the operation. To end up with a good success rate, it is very important to follow a high-quality and sterile surgical procedure. The current paper describes the standard protocol by which CS are performed by the veterinarians of the Ambulatory Clinic of the Department of Reproduction, Obstetrics, and Herd Health of the Faculty of Veterinary Medicine in Ghent (Belgium). The aim of the article is to provide a successful protocol as regards CS. We especially focus on those factors which are known to be limiting for the success of the surgery and highlight the most recent recommendations to optimize the outcome of the operation.

Bovine neonatal pancytopenia (BNP), a high fatality condition causing haemorrhages in calves aged less than 4 weeks, was first reported in 2007 in Germany and subsequently observed at low incidence in other European countries and New Zealand. A multi-country matched case-control study was conducted in 2011 to identify calf-level risk factors for BNP. 405 BNP cases were recruited from 330 farms in Belgium, France, Germany and the Netherlands by laboratory confirmation of farmer-reported cases. Up to four calves of similar age from the same farm were selected as controls (1154 calves). Risk factor data were collected by questionnaire. Multivariable modelling using conditional logistic regression indicated that PregSure®BVD (PregSure, Pfizer Animal Health) vaccination of the dam was strongly associated with BNP cases (adjusted matched Odds Ratio - amOR 17.8 first lactation dams; 95% confidence interval – ci 2.4, 134.4; p = 0.005), and second or more lactation PregSure-vaccinated dams were more likely to have a case than first lactation vaccinated dams (amOR 2.2 second lactation; ci 1.1, 4.3; p = 0.024; amOR 5.3 third or more lactation; ci 2.9, 9.8; p = <0.001). Feeding colostrum from other cows was strongly associated with BNP if the dam was not PregSure-vaccinated (amOR 30.5; ci 2.1, 440.5; p = 0.012), but the effect was less if the dam was PregSure-vaccinated (amOR 2.1; ci 1.1, 4.0; p = 0.024). Feeding exclusively dam’s milk was a higher risk than other types of milk (amOR 3.4; ci 1.6, 7.5; p = 0.002). The population attributable fractions were 0.84 (ci 0.68, 0.92) for PregSure vaccination, 0.13 (ci 0.06, 0.19) for feeding other cows’ colostrum, and 0.15 (ci 0.08, 0.22) for feeding dam’s milk. No other calf-level factors were identified, suggesting that there are other important factors that are outside the scope of this study, such as genetics, which explain why BNP develops in some PregSure-colostrum-exposed calves but not in others.

No abstract

No abstract